Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations.
4 Notable Health Tech Funding Announcements in May
Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds.
Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough
Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address.
Medical Education Is at a Crossroads. AI Isn’t the Problem — It’s the Mirror
The real question is whether we're being honest with ourselves about what medical education was designed to produce, and whether our current system is still doing that job.
Preparing Benefits For the Next Wave: Gene Therapy Medications
The rise of metabolic gene therapies represents a critical juncture for benefits management. These treatments offer genuine hope for patients with serious conditions, but they also pose significant financial challenges.